Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

InspireMD (NSPR) Cost of Revenue (2016 - 2025)

Historic Cost of Revenue for InspireMD (NSPR) over the last 16 years, with Q3 2025 value amounting to $4.4 million.

  • InspireMD's Cost of Revenue rose 19836.96% to $4.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $13.2 million, marking a year-over-year increase of 14452.87%. This contributed to the annual value of $6.1 million for FY2024, which is 3799.45% up from last year.
  • As of Q3 2025, InspireMD's Cost of Revenue stood at $4.4 million, which was up 19836.96% from $4.2 million recorded in Q2 2025.
  • In the past 5 years, InspireMD's Cost of Revenue ranged from a high of $4.4 million in Q3 2025 and a low of $776000.0 during Q2 2021
  • For the 5-year period, InspireMD's Cost of Revenue averaged around $1.6 million, with its median value being $1.1 million (2023).
  • In the last 5 years, InspireMD's Cost of Revenue plummeted by 2375.69% in 2022 and then skyrocketed by 19836.96% in 2025.
  • InspireMD's Cost of Revenue (Quarter) stood at $1.1 million in 2021, then fell by 23.76% to $828000.0 in 2022, then surged by 51.69% to $1.3 million in 2023, then surged by 52.47% to $1.9 million in 2024, then surged by 129.35% to $4.4 million in 2025.
  • Its Cost of Revenue was $4.4 million in Q3 2025, compared to $4.2 million in Q2 2025 and $2.8 million in Q1 2025.